Immunomodulating properties of newer cephalosporins: a preliminary classification.
Labro
M
M
Inserm U. 294, Laboratoire d'Hématologie et d'Immunologie, CHU Xavier Bichat 16, Paris, France.
Bryskier
A
A
D000276:Adjuvants, Immunologic; D002511:Cephalosporins / Q000494:pharmacology*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007711:Klebsiella pneumoniae / Q000187:drug effects*; D008163:Luminescent Measurements; D008826:Microbial Sensitivity Tests; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology* / Q000502:physiology; D010587:Phagocytosis; D013211:Staphylococcus aureus / Q000187:drug effects*; D013212:Staphylococcus epidermidis / Q000187:drug effects*
D000276:Adjuvants, Immunologic; D002511:Cephalosporins